Indication intelligence, analysis and sector perception

RMi Model Portfolio and Trading List

September 8, 2014 3:18pm

RegMed and cell therapy sector analysis:

What a difference three (3) quarters make - a never ending struggle!

The RegMed cell therapy sector started slowly and has stayed – variable - mostly sliding to the downside as the “divergence” accumulates into Q4.

There is STILL a lot of FEAR in the sector! I see continued weakness in “our” universe re markets and liquidity risks!

RegMed stocks “levitated” as our universe … rebounds and retreats amid speculation that … equities HAD fallen TOO far too fast.

WHY am I “cautiously optimistic” … every time we have a solid rally, it … DISSIPATES as “profiteers” swarm over slim upside “pickings”! Show me consistency for a least a week or longer!

Most investors think science is about facts and are quite frustrated when they find that development is in large part about uncertainty!

We track daily and monthly performance and market commentary incorporating quarterly tactical updates with buying and selling insights bench-marking analytics!

As market conditions change, RegMed Investors tactically re-allocates “signals” of the portfolio and provides updates with trading rationale!

Members only. Please login.

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

7 hours 42 min ago
RegMed Investors’ (RMi) pre-open: expectation versus reality

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.